期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease 被引量:9
1
作者 LIN Ying-xiang XU Wan-ning +12 位作者 LIANG Li-rong PANG Bao-sen NIE Xiu-hong ZHANG Jie WANG Hong LIU Yu-xiang WANG Dan-qi XU Zhen-yang WANG Hong-wu ZHANG Hu-sheng HE Zheng-yi YANG Ting WANG Chen 《Chinese Medical Journal》 SCIE CAS CSCD 2009年第24期2939-2944,共6页
Background The body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index was shown at predicting the risk of death, exacerbation and disease severity among patients with COPD, but few studies... Background The body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index was shown at predicting the risk of death, exacerbation and disease severity among patients with COPD, but few studies verified relationship between BODE index and health related quality of life (HRQoL) among Chinese COPD patients. The objective of this study was to evaluate the relationship between BODE index and HRQoL in cross-sectional and longitudinal association analyses. Methods A multi-center prospective cohort study was initially conducted in 491 stable COPD patients in Beijing, China. Health status (HRQoL) was assessed by St. George's Respiratory Questionnaire (SGRQ); the BODE index was calculated for each patient; dyspnea was assessed using the 5-grade Medical Research Council dyspnea scale. Other measurements included socio-demographic, body mass index (BMI), lung function test and 6-minute-walk test (6MWT). Patients were then followed monthly for 12 months. Results Only 450 patients completed the 1-year follow up and were enrolled in our present analyses. Mean age was (65.2 ±10.6)years,' men 309 (68.7%). The BODE index was categorized into 4 subgroups: 0-2, 3-4, 5-6 and 7-10. At baseline BODE index was gradually increased with baseline total SGRQ and SGRQ subscales (P trend 〈0.001). For individual components of BODE index, with the decrease of airflow limitation, and 6MWD, and with the increase of Medical Research Council (MRC) dyspnea grade, total SGRQ and SGRQ subscales were increased correspondingly, P trend 〈0.05, respectively. Similar association patterns were found between baseline BODE index and its individual components and mean SGRQ scores at the end of 1-year follow up. By multiple linear regression analyses, baseline BODE index was not only significantly associated with SGRQ score at baseline but also with SGRQ score at the end of 1-year follow up after adjustment for age, male, current smoking, 13s being 0.434 and 0.378, respectively. Conclusions BODE index is associated with SGRQ score cross-sectionally and longitudinally among stable COPD patients. BODE index might have potential to be used as a sensitive tool to assess the status of quality of life and to monitor disease progression among stable COPD patients. 展开更多
关键词 chronic obstructive pulmonary disease BODE index health-related quality of life st. george's respiratoryquestionnaire
原文传递
益气软坚消癥法提高气虚血瘀型特发性肺纤维化患者生活质量的临床研究 被引量:15
2
作者 辛大永 冯京帅 《世界中医药》 CAS 2016年第12期2714-2716,2721,共4页
目的:探讨益气软坚消癥法(二甲消癥汤)对气虚血瘀型特发性肺纤维化(IPF)患者的治疗效果。方法:收集2014年1月至2016年1月的IPF患者49例,将其随机分为2组,治疗组25例予二甲消癥汤口服,对照组24例予乙酰半胱氨酸胶囊口服,疗程3个月,随访3... 目的:探讨益气软坚消癥法(二甲消癥汤)对气虚血瘀型特发性肺纤维化(IPF)患者的治疗效果。方法:收集2014年1月至2016年1月的IPF患者49例,将其随机分为2组,治疗组25例予二甲消癥汤口服,对照组24例予乙酰半胱氨酸胶囊口服,疗程3个月,随访3个月,观察2组治疗前后及随访期圣·乔治评分(SGRQ评分)、6 min步行距离(6MWD)、中医症状积分、高分辨CT评分(HRCT)变化,及2组之间的差异。结果:治疗组在治疗3个月及随访3个月后,SGRQ评分、6WMD、中医症状积分方面与治疗前差异均有统计学意义(P<0.05);而对照组6MWD在治疗前与治疗3个月后、随访3个月后差异有统计学意义(P<0.05),其余差异均无统计学意义(P>0.05)。2组的HRCT积分均无改善。结论:二甲消癥汤能够改善特发性肺间质纤维化患者的生活质量,消除中医症状,均优于乙酰半胱氨酸组,且能够较好的维持。而治疗组及对照组均能增加患者的6MWD,治疗组优于对照组,但不能较好的维持。 展开更多
关键词 特发性肺纤维化 益气软坚消癥法 气虚血瘀 二甲消癥汤 圣·乔治评分 6分钟步行距离 中医症状积分 高分辨CT评分
下载PDF
人参蛤蚧散加减对慢性阻塞性肺疾病缓解期患者肺功能及生活质量的影响 被引量:17
3
作者 王国臣 《中医学报》 CAS 2017年第2期198-200,共3页
目的:观察人参蛤蚧散对慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)缓解期患者肺功能及生活质量的影响。方法:120例COPD缓解期(肺肾气虚证)患者随机平分为对照组和观察组,每组60例。对照组给予支气管扩张剂等常规治... 目的:观察人参蛤蚧散对慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)缓解期患者肺功能及生活质量的影响。方法:120例COPD缓解期(肺肾气虚证)患者随机平分为对照组和观察组,每组60例。对照组给予支气管扩张剂等常规治疗,观察组在对照组治疗基础上服用人参蛤蚧散。3个疗程后比较两组患者的肺功能、圣乔治呼吸问卷(Stgeorge's respiratory questionaire,SGOR)评分及临床疗效。结果:治疗后,两组患者的最大用力呼气中期流速(maximal mid-expiratory flow velocity,MMEF)、呼气峰流速值(peak expiratory flow,PEF)、第1秒用力呼气量(forced expiratory volume in 1 second,FEV1)、第1秒用力呼气量/用力肺活量(forced vital capacity,FVC)指标均较治疗前显著改善,观察组患者上述各指标改善程度显著优于对照组患者(P<0.05);观察组SGOR总评分比对照组显著下降(P<0.05);观察组有效率为90.00%,明显优于对照组68.33%(P<0.05)。结论:人参蛤蚧散治疗缓解期COPD(肺肾气虚证)患者的疗效显著,能减轻患者的临床症状及疾病的干扰,提高患者活动能力,有效提高患者的生活质量。 展开更多
关键词 人参蛤蚧散 慢性阻塞性肺疾病 肺肾气虚证 最大用力呼气中期流速 呼气峰流速值 第1秒用力呼气量 用力肺活量 圣乔治呼吸问卷评分
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部